Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)

Market Cap	44.45M
Revenue (ttm)	77.95M
Net Income (ttm)	3.35M
Shares Out	35.00M
EPS (ttm)	0.10
PE Ratio	13.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,786
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.190 - 1.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, produces, markets, and commercializes medicines and wellness consumer products. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, nervous system, gastrointestinal, dermatology, eye-ear preparations, genitourinary system and sex hormones, analgesic, respiratory system, and vitamins and natural products. It serves patients in approximately 40 countries throughout the Middle East, North Africa, and Eur...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,067
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2023, DADI's revenue was 74.88 million, an increase of 24.06% compared to the previous year's 60.36 million. Earnings were 3.16 million, an increase of 59.21%.